SV Health Investors and Third Rock Ventures have given PanOptica the money to take its lead drug into a phase 1/2 wet age-related macular degeneration (AMD) trial. PanOptica plans to start trialling ...
November 28, 2022 -- Digital Media Professionals Inc. (Headquarters: Nakano, Tokyo, President & COO: Tsuyoshi Osawa, hereafter “DMP”) is pleased to announce that it has launched “ZIA SV” Stereo Vision ...
The resurgence of AMD is nothing short of remarkable. Only a few years ago, its Opteron range was relegated primarily to the bargain bin, but now AMD processors are now rapidly taking over market ...
The core management team that hit a home run with the first vascular endothelial growth factor (VEGF) inhibitor for the eye, which resulted in a $900 million merger and acquisition deal, is taking ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback